Saturday 31 October 2026 Export LLY’s income statement to Excel — free account

Eli Lilly and Company

LLY Healthcare Drug Manufacturers General

Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024. In the quarter to June 2026, revenue grew 47.7%, EPS grew 26.2%, free cash flow grew 458.1% and total debt rose 37.6%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for five.

1,415.16 41.46 +3.02%

Follow LLY

Alert me

Market cap: $1.29T
P/E: 47.5×
Fwd P/E: 36.7×
Dividend yield: 0.47%
F-score: 7/9
Altman Z: 8.61
Beneish M: −1.91
Dividend safety: 86/100

Overview Business Profile Earnings & Analysis Segments Filings

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	37.33	46.83	32.67	40.25
P/S ratio Full definition →		11.52	14.79	11.39	13.44
P/FCF ratio Full definition →		59.65	86.31	58.67	52.49
P/Operating CF Full definition →		77.45	299.05	154.27	100.13
P/B ratio Full definition →		28.69	36.34	26.37	31.59
Price to Tangible BV Full definition →		59.48	68.31	46.50	154.68
EV/Sales Full definition →		12.13	15.34	11.88	14.01
EV/EBITDA Full definition →		29.38	35.32	25.58	31.24
EV/Operating CF Full definition →		44.89	59.45	41.92	39.75
EV/FCF Full definition →		62.85	89.46	61.21	54.75
Quick Ratio Full definition →		0.73	0.78	0.72	0.68
Current Ratio Full definition →		1.55	1.58	1.50	1.35
Net Debt/EBITDA Full definition →		3.95	3.93	3.62	4.83
Debt/Assets Full definition →		35.56%	37.79%	33.77%	38.59%
Debt/Equity Full definition →		1.71	1.60	1.26	1.62
Asset Turnover Full definition →		0.62	0.68	0.70	0.66
Operating CF/Net income Full definition →		1.58	0.49	0.72	1.51
Capex/Depreciation Full definition →		(4.44)	(4.35)	(4.57)	(5.49)
Research and Development Expense of Revenue Full definition →		19.69%	19.70%	17.73%	16.62%
Selling, General and Administrative Expense of Revenue Full definition →		15.57%	16.24%	14.82%	14.93%
Intangible Assets out of Total Assets Full definition →		0.11	0.11	0.12	0.19
Share Based Compensation of Revenue Full definition →		0.86%	0.71%	0.81%	0.87%
Graham Net Nets Full definition →		(0.04)	(0.03)	(0.04)	(0.04)
Graham Number Full definition →		110.59	123.57	148.63	159.55
Earnings Yield Full definition →		2.68%	2.14%	3.06%	2.48%
Free Cash Flow Yield Full definition →		1.68%	1.16%	1.70%	1.91%
Revenue per Share Full definition →		19.62	21.50	22.13	25.74
Operating CF per Share Full definition →		9.85	3.59	5.96	11.98
Capex per Share Full definition →		(2.33)	(2.84)	(2.60)	(3.29)
Free Cash Flow per Share Full definition →		7.52	0.76	3.36	8.69
Cash per Share Full definition →		11.05	8.10	5.91	10.03
Shareholders Equity per Share Full definition →		26.59	29.57	34.88	37.96
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		26.59	29.57	34.88	37.96
Free Cash Flow Full definition →		6,748.10	677.90	3,007.00	7,757.00
Working Capital Full definition →		21,930.40	20,401.00	18,201.00	16,931.00
Capital Expenditures Full definition →		(2,087.30)	(2,546.70)	(2,326.00)	(2,933.00)
Net Current Asset Value Full definition →		(29,013.30)	(30,312.00)	(30,543.00)	(43,732.00)
EV/EBIT Full definition →		31.85	38.00	27.23	33.19
Capex to Sales Full definition →		0.12	0.13	0.12	0.13
Price to Operating Income Full definition →		30.23	36.66	26.10	31.83
Other line items
Average Receivables Full definition →		15,754.45	16,715.50	17,590.10	20,340.30
Average Payables Full definition →		3,574.35	4,304.00	4,235.50	5,093.85
Average Inventory Full definition →		9,820.10	10,666.50	11,920.00	13,903.40
Average Assets Full definition →		95,271.15	95,595.50	102,982.40	121,602.80
Average Common Equity Full definition →		19,085.75	20,403.50	23,522.40	26,114.05

Show all line items

Columns are period end dates

Stockrow Weekly